LJHT
Laurie J. Hall Trustee Portfolio holdings
AUM
$302M
This Quarter Return
+0.01%
1 Year Return
+17.68%
3 Year Return
+82.52%
5 Year Return
+131.39%
10 Year Return
–
AUM
$259M
AUM Growth
+$259M
(-2.3%)
Cap. Flow
-$6.18M
Cap. Flow
% of AUM
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
339
New
13
Increased
11
Reduced
141
Closed
9
Top Buys
| 1 |
NVIDIA
NVDA
|
$4.24M |
| 2 |
Arch Capital
ACGL
|
$181K |
| 3 |
Medtronic
MDT
|
$161K |
| 4 |
Boston Properties
BXP
|
$141K |
| 5 |
S&P Global
SPGI
|
$62K |
Top Sells
| 1 |
GE Aerospace
GE
|
$5.45M |
| 2 |
Microsoft
MSFT
|
$615K |
| 3 |
Stryker
SYK
|
$378K |
| 4 |
Intel
INTC
|
$262K |
| 5 |
Costco
COST
|
$258K |
Sector Composition
| 1 | Healthcare | 24.7% |
| 2 | Technology | 23.9% |
| 3 | Industrials | 12.69% |
| 4 | Consumer Staples | 8.19% |
| 5 | Communication Services | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Canadian National Railway
CNI
$60.4B
| $3.12M | 1.2% |
26,970
| – | – |
|
27
Carrier Global
CARR
$55.5B
| $3.1M | 1.2% |
59,845
+600
| +1% | +$31.1K |
|
|
28
Intel
INTC
$107B
| $2.97M | 1.15% |
55,771
-4,920
| -8% | -$262K |
|
29
New York Times
NYT
$9.74B
| $2.91M | 1.12% |
59,110
+300
| +0.5% | +$14.8K |
|
30
Cigna
CI
$80.3B
| $2.88M | 1.11% |
14,408
-175
| -1% | -$35K |
|
31
Unilever
UL
$155B
| $2.75M | 1.06% |
50,645
-100
| -0.2% | -$5.42K |
|
32
Amphenol
APH
$133B
| $2.72M | 1.05% |
37,205
| – | – |
|
33
Sysco
SYY
$38.5B
| $2.68M | 1.04% |
34,152
| – | – |
|
34
AptarGroup
ATR
$9.18B
| $2.35M | 0.91% |
19,730
+100
| +0.5% | +$11.9K |
|
|
35
Medtronic
MDT
$119B
| $2.32M | 0.9% |
18,510
+1,281
| +7% | +$161K |
|
36
Becton Dickinson
BDX
$55.3B
| $2.31M | 0.89% |
9,413
| – | – |
|
37
Amazon
AMZN
$2.44T
| $2.28M | 0.88% |
694
-10
| -1% | -$32.9K |
|
38
iShares MSCI EAFE ETF
EFA
$66B
| $2.24M | 0.86% |
28,696
-1,150
| -4% | -$89.7K |
|
39
Merck
MRK
$210B
| $2.19M | 0.85% |
29,200
| – | – |
|
40
Charter Communications
CHTR
$36.3B
| $2.14M | 0.83% |
2,940
-71
| -2% | -$51.7K |
|
41
Novartis
NVS
$245B
| $2.11M | 0.82% |
25,846
| – | – |
|
42
AbbVie
ABBV
$372B
| $2.11M | 0.82% |
19,575
-1,050
| -5% | -$113K |
|
43
AT&T
T
$209B
| $2.1M | 0.81% |
77,796
-2,049
| -3% | -$55.3K |
|
44
Air Products & Chemicals
APD
$65.5B
| $2.06M | 0.79% |
8,030
-220
| -3% | -$56.3K |
|
45
State Street
STT
$32.6B
| $2.01M | 0.78% |
23,731
-275
| -1% | -$23.3K |
|
|
46
Boston Properties
BXP
$11.5B
| $1.9M | 0.73% |
17,490
+1,305
| +8% | +$141K |
|
47
Emerson Electric
EMR
$74.3B
| $1.67M | 0.64% |
17,725
-115
| -0.6% | -$10.8K |
|
48
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $1.6M | 0.62% |
31,692
| – | – |
|
49
Amgen
AMGN
$155B
| $1.56M | 0.6% |
7,335
-500
| -6% | -$106K |
|
50
Pfizer
PFE
$141B
| $1.49M | 0.57% |
34,619
| – | – |
|